DoW Tuberous Sclerosis Complex, Clinical Translational Research Award
Agency: Dept. of the Army -- USAMRAA
Assistance Listings: 12.420 -- Military Medical Research and Development
Description
Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of tuberous sclerosis complex (TSC).
Distinctive Features: This funding mechanism allows for multiple Principal Investigators (PIs). Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI(s) application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
CDMRP Help Desk
Documents
| File name | Description | Last updated |
|---|---|---|
| HT9425_FY26_TSCRP_CTRA_GO_Comments.docx | FY26 TSCRP CTRA Program Announcement | May 6, 2026 05:43 PM UTC |
Link to additional information
--
Closing: August 6, 2026
Award
$3,500,000
Program Funding
2
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
HT942526TSCRPCTRA
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
2
Posted date:
May 5, 2026
Archive date:
September 12, 2026
